Tokyo Tape
Sign in
← Soiken Holdings

Half-year report · Q2

2385.TEDINET S100V7YR
Period2024-07-01 → 2024-12-31
Filed2025-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥2.7bn2024-07-01 → 2024-12-31Cons.Net sales
Revenue¥5.2bn2023-07-01 → 2024-06-30Cons.Net sales (5-year summary)
Revenue¥2.8bn2023-07-01 → 2023-12-31Cons.Net sales
Operating income−¥203m2024-07-01 → 2024-12-31Cons.Operating income
Operating income−¥455m2023-07-01 → 2023-12-31Cons.Operating income
Ordinary income−¥198m2024-07-01 → 2024-12-31Cons.Ordinary income
Ordinary income−¥566m2023-07-01 → 2024-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income−¥449m2023-07-01 → 2023-12-31Cons.Ordinary income
Profit before tax−¥212m2024-07-01 → 2024-12-31Cons.Income before income taxes
Profit before tax−¥449m2023-07-01 → 2023-12-31Cons.Income before income taxes
Net income (owners)−¥222m2024-07-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥662m2023-07-01 → 2024-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥488m2023-07-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income−¥222m2024-07-01 → 2024-12-31Cons.Profit loss
Net income−¥489m2023-07-01 → 2023-12-31Cons.Profit loss
Total assets¥6.6bnat 2024-12-31Cons.Assets
Total assets¥6.9bnat 2024-06-30Cons.Assets
Total assets¥7.1bnat 2023-12-31Cons.Total assets (5-year summary)
Total liabilities¥557mat 2024-12-31Cons.Liabilities
Total liabilities¥697mat 2024-06-30Cons.Liabilities
Net assets / equity¥6.0bnat 2024-12-31Cons.Net assets
Net assets / equity¥6.2bnat 2024-06-30Cons.Net assets
Net assets / equity¥6.4bnat 2023-12-31Cons.Net assets (5-year summary)
Cash and deposits¥4.6bnat 2024-12-31Cons.Cash and deposits
Cash and deposits¥4.8bnat 2024-06-30Cons.Cash and deposits
Cash & equivalents¥4.6bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥4.8bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.7bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥5.9bnat 2023-06-30dCons.Cash and cash equivalents
Operating cash flow¥98m2024-07-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥881m2023-07-01 → 2024-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥967m2023-07-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥324m2024-07-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥14m2023-07-01 → 2024-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥10m2023-07-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥172,0002024-07-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥261m2023-07-01 → 2024-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥260m2023-07-01 → 2023-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-8.52024-07-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-25.322023-07-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-18.652023-07-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio91.3%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.7%at 2024-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio89.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 50
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-07-01 → 2024-12-31−¥14m
Reconciling Itemsreconcilingrevenue external2024-07-01 → 2024-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2024-07-01 → 2024-12-31−¥15m
Reconciling Itemsreconcilingsegment profit2024-07-01 → 2024-12-31−¥159m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2024-07-01 → 2024-12-31¥152m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2024-07-01 → 2024-12-31¥152m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2024-07-01 → 2024-12-31¥19m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2024-07-01 → 2024-12-31¥751m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2024-07-01 → 2024-12-31¥751m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2024-07-01 → 2024-12-31¥25m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2024-07-01 → 2024-12-31¥1.2bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2024-07-01 → 2024-12-31¥1.2bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥4m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2024-07-01 → 2024-12-31−¥132m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2024-07-01 → 2024-12-31¥183m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2024-07-01 → 2024-12-31¥173m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥11m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2024-07-01 → 2024-12-31¥3m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2024-07-01 → 2024-12-31¥393m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2024-07-01 → 2024-12-31¥393m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2024-07-01 → 2024-12-31¥39m
—segment totalrevenue2024-07-01 → 2024-12-31¥2.7bn
—segment totalrevenue external2024-07-01 → 2024-12-31¥2.7bn
—segment totalrevenue intersegment2024-07-01 → 2024-12-31¥15m
—segment totalsegment profit2024-07-01 → 2024-12-31−¥45m
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-12-31−¥10m
Reconciling Itemsreconcilingrevenue external2023-07-01 → 2023-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-12-31−¥11m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-12-31−¥156m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2023-07-01 → 2023-12-31¥176m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2023-07-01 → 2023-12-31¥176m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2023-07-01 → 2023-12-31¥1m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2023-07-01 → 2023-12-31¥779m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2023-07-01 → 2023-12-31¥779m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2023-07-01 → 2023-12-31−¥72m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2023-07-01 → 2023-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2023-07-01 → 2023-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥3m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2023-07-01 → 2023-12-31−¥270m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2023-07-01 → 2023-12-31¥165m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2023-07-01 → 2023-12-31¥157m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥8m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2023-07-01 → 2023-12-31−¥701,000
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2023-07-01 → 2023-12-31¥337m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2023-07-01 → 2023-12-31¥337m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2023-07-01 → 2023-12-31¥43m
—segment totalrevenue2023-07-01 → 2023-12-31¥2.9bn
—segment totalrevenue external2023-07-01 → 2023-12-31¥2.8bn
—segment totalrevenue intersegment2023-07-01 → 2023-12-31¥11m
—segment totalsegment profit2023-07-01 → 2023-12-31−¥299m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 447
ItemContextValueUnit
Other iaPrior1YearInstant26136000JPY
Other iaCurrentQuarterInstant23185000JPY
Intangible assetsPrior1YearInstant26136000JPY
Intangible assetsCurrentQuarterInstant23185000JPY
Investment securitiesPrior1YearInstant11465000JPY
Investment securitiesCurrentQuarterInstant11465000JPY
Other ioaPrior1YearInstant123072000JPY
Other ioaCurrentQuarterInstant113143000JPY
Investments and other assetsPrior1YearInstant134538000JPY
Investments and other assetsCurrentQuarterInstant124609000JPY
Noncurrent assetsPrior1YearInstant180990000JPY
Noncurrent assetsCurrentQuarterInstant187504000JPY
AssetsPrior1YearInstant6946134000JPY
AssetsCurrentQuarterInstant6583271000JPY
Accounts payable tradePrior1YearInstant206654000JPY
Accounts payable tradeCurrentQuarterInstant147515000JPY
Income taxes payablePrior1YearInstant2849000JPY
Income taxes payableCurrentQuarterInstant7822000JPY
Contract liabilitiesPrior1YearInstant235496000JPY
Contract liabilitiesCurrentQuarterInstant177226000JPY
Other clPrior1YearInstant235388000JPY
Other clCurrentQuarterInstant205650000JPY
Current liabilitiesPrior1YearInstant680389000JPY
Current liabilitiesCurrentQuarterInstant538214000JPY
Net defined benefit liabilityPrior1YearInstant16634000JPY
Net defined benefit liabilityCurrentQuarterInstant18289000JPY
Noncurrent liabilitiesPrior1YearInstant16634000JPY
Noncurrent liabilitiesCurrentQuarterInstant18289000JPY
LiabilitiesPrior1YearInstant697023000JPY
LiabilitiesCurrentQuarterInstant556504000JPY
Capital stockPrior1YearInstant1836587000JPY
Capital stockCurrentQuarterInstant1836587000JPY
Capital surplusPrior1YearInstant1956966000JPY
Capital surplusCurrentQuarterInstant1956966000JPY
Retained earningsPrior1YearInstant2439317000JPY
Retained earningsCurrentQuarterInstant2217032000JPY
Treasury stockPrior1YearInstant-0JPY
Treasury stockCurrentQuarterInstant-0JPY
Shareholders equityPrior1YearInstant6232871000JPY
Shareholders equityCurrentQuarterInstant6010585000JPY
Non controlling interestsPrior1YearInstant16239000JPY
Non controlling interestsCurrentQuarterInstant16181000JPY
Net assetsPrior1YearInstant6249110000JPY
Net assetsCurrentQuarterInstant6026767000JPY
Liabilities and net assetsPrior1YearInstant6946134000JPY
Liabilities and net assetsCurrentQuarterInstant6583271000JPY
Net salesPrior1YTDDuration2840385000JPY
Net salesCurrentYTDDuration2683408000JPY
Cost of salesPrior1YTDDuration1461504000JPY
Cost of salesCurrentYTDDuration1352216000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-06-30pass rounding
balance sheet identityconsolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-06-30pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-07-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-07-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-07-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-07-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-07-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2024-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass